发明名称 AMANTADINE COMPOSITIONS AND METHODS OF USE
摘要 Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
申请公布号 US2015045438(A1) 申请公布日期 2015.02.12
申请号 US201414523535 申请日期 2014.10.24
申请人 Adamas Pharmaceuticals, Inc. 发明人 Went Gregory T.;Sathyan Gayatri;Vermani Kavita;Ganapati Gangadhara;Coffee Michael;Shek Efraim;Katdare Ashok
分类号 A61K9/00;A61K31/198;A61K31/13 主分类号 A61K9/00
代理机构 代理人
主权项 1. A method of administering a dose of a drug selected from the group consisting of amantadine and pharmaceutically acceptable salts thereof to a human subject orally, once daily at a time such that the drug does not interfere with sleep, wherein the dose consists of (i) 220 mg to 445 mg of the drug and at least one excipient, wherein at least one of said excipients modifies the release of the drug to provide an extended release form, and wherein administration of the dose provides a Tmax of 6 to 18 hours as measured in a single dose human pharmacokinetic study and once daily administration provides a C-ave-day to C-ave-night ratio of 1.1 to 1.9 as determined in a multiple dose human pharmacokinetic study.
地址 Emeryville CA US